As of Jun 27
| -0.335 / -7.99%|
The 6 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 14.00, with a high estimate of 40.00 and a low estimate of 7.00. The median estimate represents a +262.69% increase from the last price of 3.86.
The current consensus among 6 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.